Compound Detail

CHEMBL5402207

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

O=C(/C=C/c1ccc2oc3ccccc3c2c1)N1CCC=C(Br)C1=O

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL5402207
Phase	Preclinical
Structure Type	MOL
InChI Key	SYHOAJOPXHJQOH-CSKARUKUSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

396.2

MW (Da)

4.64

ALogP

HBA

HBD

50.5

PSA (Å²)

0.59

QED

Ro5 Violations

Rot. Bonds

Availability	Unknown
Chirality	Unknown

First in Class Prodrug

IC50 5 meas. best 6.24

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
U-937 CHEMBL612794	IC50	6.24	6.24	574.0	1
MGC-803 CHEMBL3706566	IC50	5.7	5.7	2012.0	1
HeLa CHEMBL399	IC50	5.54	5.54	2920.0	1
MCF7 CHEMBL387	IC50	5.4	5.4	3997.0	1
HepG2 CHEMBL395	IC50	5.36	5.36	4414.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
U-937	IC50	=	574.0	nM	6.24	Antiproliferative activity against human U-937 cells assessed as inhibition of c...	36162214
MGC-803	IC50	=	2012.0	nM	5.7	Antiproliferative activity against human MGC-803 cells assessed as inhibition of...	36162214
HeLa	IC50	=	2920.0	nM	5.54	Antiproliferative activity against human HeLa cells assessed as inhibition of ce...	36162214
MCF7	IC50	=	3997.0	nM	5.4	Antiproliferative activity against human MCF7 cells assessed as inhibition of ce...	36162214
HepG2	IC50	=	4414.0	nM	5.36	Antiproliferative activity against human HepG2 cells assessed as inhibition of c...	36162214

PubMed	DOI	Target Context	# Activities
36162214	10.1016/j.ejmech.2022.114738	A549	1
36162214	10.1016/j.ejmech.2022.114738	HepG2	1
36162214	10.1016/j.ejmech.2022.114738	HeLa	1
36162214	10.1016/j.ejmech.2022.114738	MCF7	1
36162214	10.1016/j.ejmech.2022.114738	MGC-803	1
36162214	10.1016/j.ejmech.2022.114738	U-937	1

Data from ChEMBL 36 via Core Engine